Allspring Global Investments
CELU icon

Allspring Global Investments’s Celularity CELU Stock Holding History

Allspring Global Investments’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,518
Closed -$28K – 2715
2023
Q1 		$28K Buy
4,518
+3,074
+213% +$24.7K ﹤0.01% 2443
2022
Q4 		$18.6K Sell
1,444
-32
-2% -$590 ﹤0.01% 2602
2022
Q3 		$34K Buy
+1,476
New +$44.8K ﹤0.01% 2477

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Allspring Global Investments's CELU Position: Q2 2023 in Review

Allspring Global Investments sold out of Celularity (CELU) in Q2 2023, closing a stake of 4,518 shares — an estimated $28K sold.

Allspring Global Investments first reported a position in CELU in Q3 2022 and held it in 3 quarters. The position peaked at $34K in Q3 2022. 56 funds tracked by Wall St. Rank hold CELU as of Q2 2023.

  • Allspring Global Investments reported no remaining Celularity position as of Q2 2023 after selling out during the quarter.
  • Allspring Global Investments sold 4,518 Celularity shares in Q2 2023, an estimated $28K.
  • Allspring Global Investments first reported a position in Celularity in Q3 2022 and held it in 3 quarters.
  • Allspring Global Investments's Celularity position peaked at $34K in Q3 2022.
  • 56 funds tracked by Wall St. Rank held Celularity as of Q2 2023.

Based on Allspring Global Investments's 13F filing for Q2 2023, filed 18 Jul 2023.